Other markers, including CA125 and CA153, also showed a trend toward greater decline in the COPD group, although these differences did not reach statistical significance (Table 1 ).
← all excerpts
Enhanced immunotherapy response in lung adenocarcinoma patients with COPD: insights into tumor cells and immune microenvironment characteristics.
1
—
—